Stock market announcement archive

April 20, 2022
Bergen, Norway 20 April 2022Islay Venture GmbH ("Islay), a company closely related to Lifecare's ChiefScientific Officer and primary insider Prof. Dr. Dr. med Andreas Pfützner, willsubscribe 1.756.876 new shares in Lifecare AS, as part of the previously agreedconsideration from Lifecare AS to acquire Lifecare Laboratories GmbH (formelynamed Pfützner Science and Health GmbH). The acquisition and […]
Read more
April 19, 2022
Bergen, Norway 19 April 2022Lifecare AS' management team will host an online presentation of the 2021 annualresults on Thursday 21 April 2022. The webcast will be for all shareholders and interested parties at 13:00 - 14:00CET. There will be a Q&A session following the management presentation. The linkto the webcast will be available in the […]
Read more
April 4, 2022
Bergen, Norway 4 April 2022 Demonstration of nano-scale dispensing of biochemical solutions on the Sencellchip and an article in the Norwegian Technical Weekly. Upcoming events and anoperational update. Read more in the Lifecare April newsletter: https://lifecare.no/news/information-from-lifecare-april-2022/This is Lifecare Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of […]
Read more
February 28, 2022
Following the restructuring of Lifecare including the acquisition of the twooperational German subsidiaries Lifecare NanoBioSensors and LifecareLaboratories, the Lifecare Board of Directors, management, and key personnelhave conducted an inspiring and productive workshop in Mainz, Germany. Due to acurrent high demand for Covid PCR testing, Lifecare Laboratories experiences anextraordinarily high activity level, generating revenue, while LifecareNanoBioSensors […]
Read more
January 31, 2022
Bergen, Norway 31 January 2022The overall aim for Lifecare in 2022 is to initiate clinical activities in linewith our development milestones. The planned activities will bring our uniqueSencell osmotic sensing technology a significant step closer to regulatoryapproval as a medical device for diabetes care. Preparations to ensure aregulatory approved platform have been initiated and we […]
Read more
January 3, 2022
Financial calendar for Lifecare FINANCIAL YEAR 2021 21.04.2022 - Annual reportFINANCIAL YEAR 2022 06.05.2022 - Annual General Meeting25.08.2022 - Half-yearly Report This information is published pursuant to the requirements set out in theContinuing obligations.
Read more
December 20, 2021
Bergen, Norway 20 December 2021Development and preparations for first-in-human pilot study is on track asLifecare successfully has manufactured nanogranular tunneling strain (NTR)sensors on the prototype Sencell electrodes at the new Lifecare NanoBioSensorslaboratory. The manufacturing of NTR sensors is a major technical achievementfor Lifecare.Read more in the Lifecare December newsletter: https://mailchi.mp/04dca0cc9477/newsletter-december-2021This is LifecareLifecare is a Bergen-based […]
Read more
November 10, 2021
Bergen, Norway 10 November 2021Please find attached Lifecare AS' operational update for 3Q 2021. The report isalso available on https://www.lifecare.attme.dev Further informationJoacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.attme.dev, +47 40 05 90 40This information is subject to the disclosure requirements pursuant to Section5-12 the Norwegian Securities Trading Act. This stock exchange announcement waspublished by Kine Hereid, […]
Read more
November 8, 2021
Bergen, Norway 8 November 2021Please find enclosed the presentation held by Lifecare AS' CSO Prof. AndreasPfützner at the 20th annual Diabetes Tech Meeting 6 November 2021. Topic of thepresentation was the EU funded project Forget Diabetes: a novel automatedinsulin delivery system, of which Lifecare in cooperation with 6 academicpartners cross Europe aim to develop an […]
Read more
October 25, 2021
Bergen 25 October 2021Lifecare AS' management team will host an online presentation on Wednesday 10November 2021. The webcast will be for all shareholders and interested parties at 11:00 - 11:30CET. The presentation will give an operational update for the third quarter.There will be a Q&A session following the management presentation. The link tothe webcast will […]
Read more